Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds
Phase 4
Completed
- Conditions
- Nasolabial Folds
- Registration Number
- NCT00429520
- Lead Sponsor
- Merz Pharmaceuticals GmbH
- Brief Summary
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
- main inclusion criteria: severity rating scale grade 3 or 4
Read More
Exclusion Criteria
- main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Severity rating scale assessed by independent rater
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Merz Pharmaceuticals
🇩🇪Frankfurt, Germany